Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting
Crossref DOI link: https://doi.org/10.1186/s13321-019-0334-y
Published Online: 2019-02-02
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanser, Thierry
Steinmetz, Fabian P.
Plante, Jeffrey
Rippmann, Friedrich
Krier, Mireille
Text and Data Mining valid from 2019-02-02
Article History
Received: 26 September 2018
Accepted: 25 January 2019
First Online: 2 February 2019